BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28062857)

  • 21. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.
    Yang Z; Yik JH; Chen R; He N; Jang MK; Ozato K; Zhou Q
    Mol Cell; 2005 Aug; 19(4):535-45. PubMed ID: 16109377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4(+) T cells and inhibits HIV-1 gene expression.
    Budhiraja S; Ramakrishnan R; Rice AP
    Retrovirology; 2012 Jun; 9():52. PubMed ID: 22727189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA-driven cyclin-dependent kinase regulation: when CDK9/cyclin T subunits of P-TEFb meet their ribonucleoprotein partners.
    Michels AA; Bensaude O
    Biotechnol J; 2008 Aug; 3(8):1022-32. PubMed ID: 18655042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.
    Jang MK; Mochizuki K; Zhou M; Jeong HS; Brady JN; Ozato K
    Mol Cell; 2005 Aug; 19(4):523-34. PubMed ID: 16109376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.
    Amin KS; Jagadeesh S; Baishya G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
    Mol Cancer Ther; 2014 Feb; 13(2):341-52. PubMed ID: 24258347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
    Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
    J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradation.
    Liu X; Han W; Gulla S; Simon NI; Gao Y; Cai C; Yang H; Zhang X; Liu J; Balk SP; Chen S
    Oncotarget; 2016 Jan; 7(2):1754-64. PubMed ID: 26636645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.
    Hu Q; Poulose N; Girmay S; Helevä A; Doultsinos D; Gondane A; Steele RE; Liu X; Loda M; Liu S; Tang DG; Mills IG; Itkonen HM
    RNA Biol; 2021 Nov; 18(sup2):722-729. PubMed ID: 34592899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.
    Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE
    Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors.
    Richters A; Doyle SK; Freeman DB; Lee C; Leifer BS; Jagannathan S; Kabinger F; Koren JV; Struntz NB; Urgiles J; Stagg RA; Curtin BH; Chatterjee D; Mathea S; Mikochik PJ; Hopkins TD; Gao H; Branch JR; Xin H; Westover L; Bignan GC; Rupnow BA; Karlin KL; Olson CM; Westbrook TF; Vacca J; Wilfong CM; Trotter BW; Saffran DC; Bischofberger N; Knapp S; Russo JW; Hickson I; Bischoff JR; Gottardis MM; Balk SP; Lin CY; Pop MS; Koehler AN
    Cell Chem Biol; 2021 Feb; 28(2):134-147.e14. PubMed ID: 33086052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA GAS5 interacts and suppresses androgen receptor activity in prostate cancer cells.
    Lv S; Pu X; Luo M; Wen H; Xu Z; Wei Q; Dang Q
    Prostate; 2021 Sep; 81(12):893-901. PubMed ID: 34184786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target.
    Shiota M; Yokomizo A; Naito S
    J Mol Endocrinol; 2011 Aug; 47(1):R25-41. PubMed ID: 21504942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 7SK snRNA-mediated, gene-specific cooperativity of HMGA1 and P-TEFb.
    Eilebrecht S; Benecke BJ; Benecke A
    RNA Biol; 2011; 8(6):1084-93. PubMed ID: 21957495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding.
    Egloff S; Van Herreweghe E; Kiss T
    Mol Cell Biol; 2006 Jan; 26(2):630-42. PubMed ID: 16382153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Activation of P-TEFb Complexes in the Development of Cardiomyocyte Hypertrophy following Activation of Distinct G Protein-Coupled Receptors.
    Martin RD; Sun Y; MacKinnon S; Cuccia L; Pagé V; Hébert TE; Tanny JC
    Mol Cell Biol; 2020 Jun; 40(14):. PubMed ID: 32341082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1.
    Chen S; Kesler CT; Paschal BM; Balk SP
    J Biol Chem; 2009 Sep; 284(38):25576-84. PubMed ID: 19622840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.
    Hao J; Ci X; Wang Y; Choi SYC; Sullivan SE; Xue H; Wu R; Dong X; Haegert AM; Collins CC; Lin D; Wang Y
    Int J Cancer; 2021 Jan; 148(2):469-480. PubMed ID: 33038264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.